|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US5830702A
(en)
|
1990-10-31 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
|
|
US7820180B2
(en)
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
|
US7662396B2
(en)
|
2001-03-26 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US20070264279A1
(en)
|
1994-11-08 |
2007-11-15 |
Claudia Gravekamp |
Compositions and methods comprising a MAGE-b antigen
|
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
|
US6051237A
(en)
|
1994-11-08 |
2000-04-18 |
The Trustees Of The University Of Pennsylvania |
Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
|
|
US8791237B2
(en)
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US7794729B2
(en)
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
|
US8114414B2
(en)
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
|
EP2298900A1
(en)
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
|
US6099848A
(en)
|
1997-11-18 |
2000-08-08 |
The Trustees Of The University Of Pennsylvania |
Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
|
|
GB9726555D0
(en)
|
1997-12-16 |
1998-02-11 |
Smithkline Beecham Plc |
Vaccine
|
|
US20030138808A1
(en)
*
|
1998-02-19 |
2003-07-24 |
Simard John J.L. |
Expression vectors encoding epitopes of target-associated antigens
|
|
WO2001041782A2
(en)
|
1999-12-09 |
2001-06-14 |
Chiron Corporation |
Method for administering a cytokine to the central nervous system and the lymphatic system
|
|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
JP2004500405A
(ja)
|
2000-03-29 |
2004-01-08 |
ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア |
抗原の免疫原性を増強するための組成物および方法
|
|
US6855320B2
(en)
|
2000-03-29 |
2005-02-15 |
The Trustees Of The University Of Pennsylvania |
Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
|
|
US7700344B2
(en)
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
AUPR446801A0
(en)
*
|
2001-04-18 |
2001-05-17 |
University Of Queensland, The |
Novel compositions and uses therefor
|
|
AU2004204751A1
(en)
|
2003-01-09 |
2004-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
|
|
US7855064B2
(en)
|
2004-08-13 |
2010-12-21 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free vaccines and methods for constructing and using same
|
|
ES2543079T3
(es)
|
2004-08-13 |
2015-08-14 |
The Trustees Of The University Of Pennsylvania |
Métodos para construir vacunas sin resistencia antibiótica
|
|
US7858097B2
(en)
|
2004-08-13 |
2010-12-28 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free Listeria strains and methods for constructing and using same
|
|
US9034650B2
(en)
|
2005-02-02 |
2015-05-19 |
Intrexon Corporation |
Site-specific serine recombinases and methods of their use
|
|
US7935804B2
(en)
*
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
US8241636B2
(en)
|
2006-08-15 |
2012-08-14 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
EP2147092A4
(en)
|
2007-04-16 |
2010-06-09 |
Univ Pennsylvania |
ANTIBIOTIC RESISTANCE-FREE LISTERIA TRIBES AND METHOD OF CONSTRUCTING AND USING THEREOF
|
|
US20150366955A9
(en)
|
2009-11-11 |
2015-12-24 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US20140234370A1
(en)
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US20120135033A1
(en)
|
2008-05-19 |
2012-05-31 |
Anu Wallecha |
Multiple delivery system for heterologous antigens
|
|
JP5757863B2
(ja)
*
|
2008-05-19 |
2015-08-05 |
アドバクシス インコーポレイテッド |
異種抗原のための二重送達システム
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
US8778329B2
(en)
|
2009-03-04 |
2014-07-15 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising angiogenic factors and methods of use thereof
|
|
JP5985397B2
(ja)
|
2009-11-11 |
2016-09-06 |
アドバクシス インコーポレイテッド |
組換えリステリア株およびそれを含む免疫原性組成物
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
|
US20110305724A1
(en)
|
2010-04-19 |
2011-12-15 |
Yvonne Paterson |
Immunotherapeutic, anti-tumorigenic compositions and methods of use thereof
|
|
CN107412756A
(zh)
|
2010-10-01 |
2017-12-01 |
宾夕法尼亚大学理事会 |
李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途
|
|
CA2829960A1
(en)
|
2011-03-11 |
2012-09-20 |
John Rothman |
Listeria-based adjuvants
|
|
BR112014022662A2
(pt)
|
2012-03-12 |
2017-10-03 |
Advaxis Inc |
Inibição da função de célula supressora seguindo tratamento de vacina de listeria
|
|
AU2013370210B2
(en)
|
2012-12-27 |
2018-06-14 |
Aduro Biotech, Inc. |
Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof
|
|
CN103550789B
(zh)
*
|
2013-11-25 |
2015-04-22 |
苏州大学 |
以减毒沙门氏菌为载体的口服肿瘤疫苗的制备及其应用
|
|
CA2947358A1
(en)
|
2014-02-18 |
2015-08-27 |
Advaxis, Inc. |
Biomarker directed multi-target immunotherapy
|
|
AU2015223136A1
(en)
|
2014-02-25 |
2016-09-22 |
Advaxis, Inc. |
Compositions and methods for the treatment of HER2/Neu over-expressing tumors
|
|
SG11201607213QA
(en)
|
2014-03-05 |
2016-09-29 |
Advaxis Inc |
Methods and compositions for increasing a t-effector cell to regulatory t cell ratio
|
|
AU2015250111A1
(en)
|
2014-04-24 |
2016-12-08 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of producing the same
|
|
SG11201609135VA
(en)
|
2014-05-02 |
2016-11-29 |
Univ Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of her-2-positive cancers
|
|
WO2016011357A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
|
|
EP3169356A4
(en)
|
2014-07-18 |
2018-03-28 |
Advaxis, Inc. |
Recombinant listeria strain expressing heterologous antigen fusion proteins and methods of use thereof
|
|
WO2016011320A1
(en)
|
2014-07-18 |
2016-01-21 |
Advaxis, Inc. |
Bivalent listeria-based delivery system of heterologous antigens
|
|
CN106794235A
(zh)
|
2014-07-18 |
2017-05-31 |
阿德瓦希斯公司 |
用于引起抗肿瘤应答的基于李斯特菌的免疫原性组合物
|
|
SG11201702857PA
(en)
|
2014-10-14 |
2017-05-30 |
Univ Pennsylvania |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
MA41217A
(fr)
|
2014-12-19 |
2017-10-24 |
Advaxis Inc |
Polythérapies ayant des souches de listeria recombinées
|
|
WO2016126876A2
(en)
|
2015-02-03 |
2016-08-11 |
Advaxis, Inc. |
Listeria-based adjuvants
|
|
US20160220652A1
(en)
|
2015-02-03 |
2016-08-04 |
Advaxis, Inc. |
Methods of using recombinant listeria vaccine strains in disease immunotherapy
|
|
WO2016126878A2
(en)
|
2015-02-03 |
2016-08-11 |
The Trustees Of The University Of Pennsylvania |
Listeria-based immunomodulation
|
|
MA41644A
(fr)
|
2015-03-03 |
2018-01-09 |
Advaxis Inc |
Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation
|
|
WO2016154412A2
(en)
|
2015-03-26 |
2016-09-29 |
The Trustees Of The University Of Pennsylvania |
Combination of a pd-1 antagonist and a listeria based vaccine for treating pancreatic cancer
|
|
US20180104284A1
(en)
|
2015-05-13 |
2018-04-19 |
Advaxis, Inc. |
Immunogenic Listeria-Based Compositions Comprising Truncated Acta-Antigen Fusions And Methods Of Use Thereof
|
|
TW201708536A
(zh)
|
2015-05-26 |
2017-03-01 |
艾法西斯公司 |
個人化的基於遞送載體之免疫療法及其用途
|
|
EP3313975A4
(en)
|
2015-06-24 |
2019-03-13 |
Advaxis, Inc. |
MANUFACTURING DEVICE AND METHOD FOR PERSONALIZED ADMINISTRATION OF VECTOR-BASED IMMUNOTHERAPY
|
|
MA42841A
(fr)
|
2015-09-15 |
2018-07-25 |
Advaxis Inc |
Procédé de fabrication d'une formulation immunothérapeutique comprenant une souche de listeria de recombinaison
|
|
WO2017048850A1
(en)
*
|
2015-09-15 |
2017-03-23 |
Advaxis, Inc. |
Listeria-based immunogenic compositions and methods of use thereof in cancer prevention and treatment
|
|
JP2018527382A
(ja)
|
2015-09-17 |
2018-09-20 |
アドバクシス， インコーポレイテッド |
組み換え型リステリアワクチン株および癌免疫療法におけるその使用方法
|
|
AU2016340148A1
(en)
|
2015-10-14 |
2018-05-31 |
Advaxis, Inc. |
Recombinant Listeria strains and methods of using the same in cancer immunotherapy
|
|
US20180325964A1
(en)
|
2015-11-20 |
2018-11-15 |
Advaxis, Inc. |
Manufacturing device and method of an immunotherapeutic formulation comprising a recombinant listeria strain
|
|
TW201726171A
(zh)
|
2015-12-16 |
2017-08-01 |
艾法西斯公司 |
以李斯特菌屬為主的免疫治療及其用法
|
|
CA3012829A1
(en)
|
2016-01-27 |
2017-08-03 |
Advaxis, Inc. |
Personalized delivery vector-based immunotherapy and uses thereof
|
|
CA3029235A1
(en)
|
2016-07-05 |
2018-01-11 |
Advaxis, Inc. |
Listeria-based immunogenic compositions comprising wilms tumor protein antigens and methods of use thereof
|
|
MA46721A
(fr)
|
2016-11-07 |
2019-09-11 |
Advaxis Inc |
Combinaison d'un vaccin à base de listeria avec des anticorps anti-ctla-4 ou anti-cd137
|
|
WO2018102585A1
(en)
|
2016-11-30 |
2018-06-07 |
Advaxis, Inc. |
Personalized immunotherapy in combination with immunotherapy targeting recurrent cancer mutations
|
|
KR20190082850A
(ko)
|
2016-11-30 |
2019-07-10 |
어드박시스, 인크. |
반복되는 암 돌연변이를 표적화하는 면역원 조성물 및 그것의 사용 방법
|
|
WO2018129306A1
(en)
|
2017-01-05 |
2018-07-12 |
Advaxis, Inc. |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
WO2018170313A1
(en)
|
2017-03-16 |
2018-09-20 |
Advaxis, Inc. |
Methods and compositions for increasing efficacy of vaccines
|
|
WO2019006401A2
(en)
|
2017-06-30 |
2019-01-03 |
Advaxis, Inc. |
LISTERIA-BASED IMMUNOGENIC COMPOSITIONS COMPRISING HETERICCLIENT WILMS TUMOR PROTEIN ANTIGENS AND METHODS OF USE THEREOF
|
|
JP7284156B2
(ja)
|
2017-09-19 |
2023-05-30 |
アドバクシス， インコーポレイテッド |
細菌またはＬｉｓｔｅｒｉａ株の凍結乾燥のための組成物および方法
|
|
US20210177955A1
(en)
|
2017-11-08 |
2021-06-17 |
Advaxis, Inc. |
Immunogenic heteroclitic peptides from cancer-associated proteins and methods of use thereof
|
|
WO2019157098A1
(en)
|
2018-02-06 |
2019-08-15 |
Advaxis, Inc. |
Compositions comprising a recombinant listeria strain and an anti-ccr8 antibody and methods of use
|
|
US20210003558A1
(en)
|
2018-03-09 |
2021-01-07 |
Advaxis, Inc. |
Compositions and methods for evaluating attenuation and infectivity of listeria strains
|
|
EP3785029A1
(en)
|
2018-04-27 |
2021-03-03 |
Advaxis, Inc. |
Compositions and methods for evaluating potency of listeria-based immunotherapeutics
|